| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.07B | 59.20B | 47.77B | 44.59B | 45.44B | 48.75B |
| Gross Profit | 13.77B | 13.21B | 11.36B | 8.68B | 8.31B | 8.02B |
| EBITDA | 7.90B | 7.76B | 8.37B | 5.04B | 4.17B | 4.19B |
| Net Income | 5.13B | 4.88B | 5.40B | 3.04B | 2.55B | 2.51B |
Balance Sheet | ||||||
| Total Assets | 63.48B | 66.17B | 63.17B | 54.48B | 52.49B | 53.52B |
| Cash, Cash Equivalents and Short-Term Investments | 10.77B | 10.82B | 15.18B | 13.12B | 11.23B | 7.05B |
| Total Debt | 3.30B | 3.30B | 3.30B | 3.30B | 3.30B | 3.30B |
| Total Liabilities | 25.38B | 27.94B | 28.59B | 24.15B | 25.18B | 28.23B |
| Stockholders Equity | 38.09B | 38.23B | 34.58B | 30.32B | 27.31B | 25.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.39B | -817.00M | 82.00M | 4.18B | -3.07B |
| Operating Cash Flow | 0.00 | -3.31B | 1.36B | 996.00M | 5.12B | -2.59B |
| Investing Cash Flow | 0.00 | 43.00M | 1.37B | 1.35B | -558.00M | 831.00M |
| Financing Cash Flow | 0.00 | -1.05B | -854.00M | -533.00M | -512.00M | -477.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥133.61B | 21.86 | 12.54% | 1.84% | 13.86% | 51.05% | |
72 Outperform | ¥75.82B | 11.99 | 16.37% | 2.79% | 31.48% | 16.11% | |
72 Outperform | ¥911.96B | 16.97 | 6.61% | 1.58% | 5.02% | -27.41% | |
69 Neutral | ¥211.62B | 10.37 | 9.02% | 3.11% | 1.25% | -3.97% | |
68 Neutral | ¥732.16B | 23.01 | ― | 1.43% | 7.87% | 38.32% | |
66 Neutral | ¥198.36B | -49.70 | ― | 2.41% | 2.47% | 1.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |